NEW YORK (GenomeWeb News) – BGS Acquisition today announced it is purchasing genotyping firm TransnetYX Holding Corp. in a cash and stock deal.

BGS is buying TransnetYX as part of an amended and restated merger agreement with diversified holding company Black Diamond Holdings. The two firms had announced in June an agreement to complete a business combination. The deal included TransnetYX, in which Black Diamond has a majority stake.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Chan Zuckerberg Initiative is investing in Cold Spring Harbor Laboratory's BioRxiv.

A study appearing in PLOS One finds that shortened consent forms don't affect clinical trial participants' understanding of the study.

The National Security Agency monitored signal intelligence for signs of "nefarious" genetic engineering projects, Gizmodo reports.

In Nature this week: barley genome sequenced, method for genotyping and phasing short tandem repeats, and more.